Adjuvant therapy for Asian patients with resected stage III/IV BRAF V600-mutant melanoma with more than 3 years of follow-up: A multicenter retrospective study in Japan

Saved in:
Bibliographic Details
Published in:EJC skin cancer 2024, Vol.2, p.100182, Article 100182
Main Authors: Namikawa, K., Mori, S., Kiniwa, Y., Takenouchi, T., Nakamura, M., Oashi, K., Yoshikawa, S., Muto, Y., Uchi, H., Yoshino, K., Maekawa, T., Ohe, S., Uhara, H., Ichigozaki, Y., Asai, J., Nakamura, Y., Ishizuki, S., Matsuzawa, T., Kitagawa, H., Nomura, M., Funakoshi, T., Matsushita, S., Maeda, T., Hatta, N., Tsutsui, K., Nakagawa, T., Hoashi, T., Ishikawa, H., Nakama, K., Ito, T., Miyagawa, T., Nishizawa, A., Yanagi, T., Kato, Y., Fujiwara, S., Yamamoto, Y., Iwata, H., Ogata, D., Fujisawa, Y.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2772-6118
2772-6118
DOI:10.1016/j.ejcskn.2024.100182